Heron Therapeutics, Inc./DE – ‘10-Q’ for 3/31/15 – ‘EXCEL’

On:  Friday, 5/8/15, at 3:23pm ET   ·   For:  3/31/15   ·   Accession #:  1193125-15-179414   ·   File #:  1-33221

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    164K 
 2: EX-10.1     Material Contract                                   HTML     20K 
 3: EX-10.2     Material Contract                                   HTML     20K 
 4: EX-10.3     Material Contract                                   HTML     15K 
 5: EX-10.4     Material Contract                                   HTML     18K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
24: R1          Document And Entity Information                     HTML     39K 
19: R2          Condensed Consolidated Balance Sheets (Current      HTML     76K 
                Period Unaudited)                                                
22: R3          Condensed Consolidated Statements of Operations     HTML     38K 
                (Unaudited)                                                      
26: R4          Condensed Consolidated Statements of Cash Flows     HTML     76K 
                (Unaudited)                                                      
34: R5          Note 1 - Business                                   HTML     31K 
20: R6          Note 2 - Basis of Presentation                      HTML     18K 
21: R7          Note 3 - Accounting Policies                        HTML     37K 
18: R8          Note 4 - Convertible Notes to Related Parties       HTML     23K 
16: R9          Note 5 - Stockholders' Equity                       HTML     79K 
35: R10         Note 6 - Income Taxes                               HTML     20K 
28: R11         Significant Accounting Policies (Policies)          HTML     52K 
27: R12         Note 3 - Accounting Policies (Tables)               HTML     23K 
31: R13         Note 5 - Stockholders' Equity (Tables)              HTML     64K 
32: R14         Note 1 - Business (Details Textual)                 HTML     24K 
30: R15         Note 3 - Accounting Policies - Equity Excluded      HTML     25K 
                From Calculation of Diluted Earnings Per Share                   
                (Details)                                                        
33: R16         Note 4 - Convertible Notes to Related Parties       HTML     66K 
                (Details Textual)                                                
23: R17         Note 5 - Stockholders' Equity (Details Textual)     HTML     94K 
25: R18         Note 5 - Stockholders' Equity - Allocation of the   HTML     24K 
                Recognized Cost (Details)                                        
29: R19         Note 5 - Stockholders' Equity - Option Valuation    HTML     26K 
                Assumptions (Details)                                            
38: R20         Note 5 - Stockholders' Equity - Option Summary      HTML     40K 
                (Details)                                                        
37: XML         IDEA XML File -- Filing Summary                      XML     49K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX     56K 
17: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    261K 
 9: EX-101.INS  XBRL Instance -- hrtx-20150331                       XML    390K 
11: EX-101.CAL  XBRL Calculations -- hrtx-20150331_cal               XML     53K 
12: EX-101.DEF  XBRL Definitions -- hrtx-20150331_def                XML    382K 
13: EX-101.LAB  XBRL Labels -- hrtx-20150331_lab                     XML    358K 
14: EX-101.PRE  XBRL Presentations -- hrtx-20150331_pre              XML    391K 
10: EX-101.SCH  XBRL Schema -- hrtx-20150331                         XSD     65K 
36: ZIP         XBRL Zipped Folder -- 0001193125-15-179414-xbrl      Zip     53K 

‘EXCEL’   —   IDEA Workbook of Financial Reports (.xls)

This is an IDEA Workbook.

	Download this Microsoft® Excel® .xls workbook
Web Archive:	This document is a Single File Web Page, also known as         a Web Archive file.  To view this Workbook file format,         your browser or editor must support Web Archive files.

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Heron Therapeutics, Inc./DE       10-K       12/31/23   72:10M                                    Donnelley … Solutions/FA
 3/29/23  Heron Therapeutics, Inc./DE       10-K       12/31/22   73:12M                                    Donnelley … Solutions/FA
 2/28/22  Heron Therapeutics, Inc./DE       10-K       12/31/21   74:12M                                    ActiveDisclosure/FA
 2/24/21  Heron Therapeutics, Inc./DE       10-K       12/31/20   74:12M                                    ActiveDisclosure/FA